
IMBiologics
Operator of a biotechnology company intended to invent novel treatment options for autoimmune diseases and cancer. The company offers an immunomodulatory antibody drug, an antibody-based-immune modula...
Valuation
$0
Share Price
N/A
Total Raised
$63.7M
Last Round
N/A